Pharmaceutical Patents and Prices : A Preliminary Empirical Assessment Using Data from India

The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing product patents on prices and utilization of drugs in the Central Nervous System market in India. The Central Nervous System segment is the second largest therapeutic category in terms of retail sales in the world and is one of the fastest growing segments in India. Using information on product patents granted by the government and panel data on pharmaceutical prices and utilization from 2003-2008, the paper finds limited evidence of overall price increase following the introduction of product patents. However, there appear to be heterogeneous effects on prices by the type of product patent granted on drugs, implying the need for a careful examination of the product patent portfolio.

Bibliographic Details

Main Authors:	Duggan, Mark, Goyal, Aparajita
Language:	English
Published:	World Bank, Washington, DC 2012-05
Subjects:	ACCESS TO PHARMACEUTICALS, ACTIVE INGREDIENTS, ADVERTISING, ANALGESICS, ANTIBIOTICS, AUDITS, AVERAGE PRICE, AVERAGE PRICES, BRAND, BRAND NAME, BRANDS, CAPSULES, CHEMISTS, COMBINATION DRUGS, COPYRIGHTS, DELIVERY SYSTEMS, DOSAGE FORMS, DRUG PRICES, DRUGS, GOVERNMENT POLICY, HEALTH CARE, HOSPITALS, IMPORTED DRUGS, INFORMATION ON PRODUCT, INFRINGEMENT, INNOVATIONS, INTELLECTUAL PROPERTY, INTELLECTUAL PROPERTY PROTECTION, INTELLECTUAL PROPERTY RIGHTS, INVENTION, INVENTIONS, JOINT VENTURES, LAWS, LEGAL PROTECTION, LICENSE, LICENSES, LICENSING, MANUFACTURING, MARGINAL COSTS, MARKET ENTRY, MARKET POWER, MARKET RESEARCH, MARKET RESEARCH FIRM, MARKET STRUCTURE, MARKETING, MARKETING STRATEGIES, MATERIAL, MEDICINE, OPEN ACCESS, PATENT, PATENT ACT, PATENT APPLICATION, PATENT APPLICATIONS, PATENT LAW, PATENT LAWS, PATENT LEGISLATION, PATENT OFFICES, PATENT POLICIES, PATENT PROTECTION, PATENT REFORM, PATENT RIGHTS, PATENT SYSTEMS, PATENT TERM, PATENTABILITY, PATENTED PRODUCTS, PERSONAL COMMUNICATION, PHARMACEUTICAL, PHARMACEUTICAL INDUSTRY, PHARMACEUTICAL LAW, PHARMACEUTICAL MANUFACTURERS, PHARMACEUTICAL PATENTS, PHARMACEUTICAL PRICES, PHARMACEUTICAL PRICING, PHARMACEUTICAL PRODUCTS, PHARMACEUTICAL SECTOR, PHARMACEUTICAL TREATMENTS, PHARMACEUTICALS INDUSTRY, PHARMACOECONOMICS, PHARMACY, PRICE CHANGE, PRICE COMPETITION, PRICE CONTROL, PRICE CONTROLS, PRICE INCREASE, PRICE INCREASES, PRICING POLICY, PROCUREMENT, PRODUCTION PROCESS, PUBLIC HEALTH, PURCHASING, R&D, RESEARCH INVESTMENT, RESULT, RESULTS, RETAIL, RETAIL SALES, RETENTION, SALES, SEDATIVES, SUBSTITUTES, SUBSTITUTION, SUPPLIER, TABLETS, TECHNICAL COOPERATION, TECHNOLOGICAL INNOVATION, TECHNOLOGY TRANSFERS, TIME PERIOD, TOTAL SALES, TRADEMARKS, USES, VACCINES, WEB, WORLD TRADE,
Online Access:	http://documents.worldbank.org/curated/en/2012/05/16258614/pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india-pharmaceutical-patents-prices-preliminary-empirical-assessment-using-data-india https://hdl.handle.net/10986/9342
Tags:	Add Tag No Tags, Be the first to tag this record!